News About: Pharm. Industry
26 multination firms’ annual salary stands at 68 million won
Employees of 26 foreign invested firms here earned an average of 68 million won last year, with Abbott Korea workers topping the list, data showed Monday.
According to Yakup.com, a Web site which tracks the nation’...
Monthly sales per capita in multinational firms average 57 million won
Monthly sales per capita in 26 foreign invested drug firms here averaged 57 million won last year and annual sales per capita stood at 685 million won, a local Web site said Monday.
According to Yakup.com, a pharma...
Dongwha Pharm teams up with Cinfa Laboratories
Dongwha Pharmaceutical, Korea’s leading drug manufacturer, said Friday that it has established a marketing and distribution partnership with a Korean unit of Spain based Cinfa Laboratories.
Under the deal, Dongwha ...
Multinational drug firms’ revenues fall 3% on slump
Twenty-six multinational drug makers saw their combined sales drop 2.6 percent in 2012 from a year earlier, an online pharmaceutical information provider said Friday, pointing to their troubles stemming from the gover...
36 Korean drug makers reap over 100 billion won in 2012 sales
Korea’s 36 listed or non-listed drug firms recorded more than 100 billion won in sales last year, data showed Friday.
Combined sales by the 36 companies rose 3 percent to 9.84 trillion won in the fiscal year 2012, ...
Pharmaceutical lobby groups call for careful implementation of new drug reform
Korea’s four drug lobby groups, such as the Korea Pharmaceutical Manufacturers Association, the Korea Drug Research Association, the Korean Research-based Pharmaceutical Industry Association and the Korea Biomedicine ...
GSK keeps top spot in 2012 sales
GSK kept its number 1 ranking in terms of revenue last year from the leader board of multinational drug makers, but struggles this year against Novartis Korea which continued to overtake the top position, according to...
Big five hold 66 flagship products of over 10 billion won in annual sales
The country’s five market leaders, such as Dong-A Pharmaceutical, Daewoong Pharmaceutical, Green Cross Corp., Yuhan Corp. and Hanmi Pharmaceutical, have a total of 66 products reaping over 10 billion won in annual sal...
Viagra dethroned as top spotPfizer’s Viagra has boasted the highest annual revenue in Korea’s competitive impotence market since its release in October 1999. But last year, Viagra gave up its top position ...
|
Hanmi’s U.S. partner starts phase-2 trial for long-acting LAPS-GCSF in patients with breast cancer
Hanmi’s U.S. partner starts phase-2 trial for long-acting LAPS-GCSF in patients with breast cancer
Hanmi Pharmaceutical Co. said Tuesday that its U.S. partner Spectrum Pharmaceuticals has initiated a Phase-2 clinic...
